Biostrategies LC
Jonesboro, AR
- UEI
- PE6MEQZRFW63
- CAGE
- 4BJ87
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- Arkansas State University - Biosciences Institute, 504 University Loop, Jonesboro, AR 72401, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Biostrategies LC
Biostrategies LC is a for-profit, veteran-owned limited liability company located at Arkansas State University's Biosciences Institute in Jonesboro, Arkansas. The company specializes in advanced biotechnology research, focusing on developing innovative gene therapy and enzyme replacement therapies for rare genetic disorders. Its primary expertise lies in creating novel therapeutic approaches that can effectively deliver enzymes across complex biological barriers, particularly the blood-brain barrier, to treat devastating neurological and genetic conditions.
Biostrategies LC has secured multiple federal grants from key National Institutes of Health (NIH) institutes, including the National Eye Institute, National Institute of Child Health and Human Development, and National Institute of Neurological Disorders and Stroke. Their grant-funded research targets specific rare genetic disorders such as GM1 gangliosidosis, Morquio A syndrome (MPS-IVA), Sanfilippo A syndrome (MPS IIIA), and Krabbe disease. The company's innovative approach involves developing advanced gene therapy techniques that use adeno-associated virus (AAV) vectors combined with a lectin-based delivery technology (RTB) to produce functional replacement enzymes. These therapies aim to systematically deliver corrective enzymes across the blood-brain barrier, potentially offering the first effective treatments for these debilitating genetic disorders. Their research focuses on creating therapeutic interventions that can prevent neurological degradation, improve patients' quality of life, and potentially extend life expectancy for individuals with these rare genetic conditions.
SBA capabilities narrative
Research, development, and manufacture of plant-based bioproduction of human and agricultural vaccines, therapeutics, and neutraceuticals.
Quick answers
What is Biostrategies LC's UEI?
Biostrategies LC's Unique Entity ID (UEI) in SAM.gov is PE6MEQZRFW63.
What is Biostrategies LC's CAGE code?
Biostrategies LC's CAGE code is 4BJ87.
What is Biostrategies LC's primary NAICS code?
Biostrategies LC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Biostrategies LC located?
Biostrategies LC's physical address in SAM.gov is Arkansas State University - Biosciences Institute, 504 University Loop, Jonesboro, AR 72401, USA.
Is Biostrategies LC registered in SAM.gov?
Yes. Biostrategies LC's SAM.gov registration is active through February 27, 2027.
What is Biostrategies LC's most recent federal award?
Biostrategies LC's most recent federal grant award is Treatment of GM1 gangliosidosis CNS manifestations by AAV systemic expression of lectin-enhanced enzyme -… (R44NS141514), from National Institute of Neurological Disorders and Stroke, on September 15, 2025.
On GovTribe
See Biostrategies LC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors